Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MLL |
| Upstream (Parents) |
|---|
| (<<) NR2F6 → MLL |
| (<<) CSDA → MLL |
| (<<) TSC22D4 → MLL |
| (<<) PEG3 → MLL |
| (<<) MYC → MLL |
| (<<) TCF12 → MLL |
| (<<) CEBPA → MLL |
| (<<) TAF4B → MLL |
| (<<) RXRA → MLL |
| Downstream (Children) |
|---|
| MLL → ATOH1 (>>) |
| MLL → MYT1L (>>) |
| MLL → NFKB2 (>>) |
| MLL → OLIG2 (>>) |
| MLL → GBX2 (>>) |
| MLL → ZHX3 (>>) |
| MLL → POU2F2 (>>) |
| MLL → SOX1 (>>) |
| MLL → THRB (>>) |
| MLL → KLF1 (>>) |
| MLL → NFYA (>>) |
